The United Nations Secretary-General’s High-Level Panel on Access to Medicines

Promoting innovation and access to health technologies

by Judith Levine, Roy Small, Julia Stewart
UNDP in collaboration with UNAIDS, September 2016

70 pp. 3.3 MB
http://www.ip-watch.org/weblog/wp-content/uploads/2016/09/HLP-Access-to-
Medicines-Final-Report-Sept-2016.pdf
image-003_resize

The long-awaited report by the United Nations High Level Panel on Access to Medicines was released, making many recommendations. The panel calls for countries to embrace the policy space available in the World Trade Organization intellectual property rules, and invest more in health. It also calls for negotiation of a binding international treaty on research and development, delinking prices from R&D costs, greater transparency in drug pricing, public health impact assessments in free trade agreements, and encouragement to better use international legal tools available to countries to ensure affordable medical products.

(Visited 14 times, 1 visits today)
This entry was posted in Essential Medicines, General. Bookmark the permalink.